ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 374 filers reported holding ROYALTY PHARMA PLC in Q2 2024. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,356,367 | -60.1% | 51,436 | -57.5% | 0.13% | -66.0% |
| Q4 2023 | $3,400,547 | +15.5% | 121,059 | +11.6% | 0.38% | +1.3% |
| Q3 2023 | $2,943,577 | +178.2% | 108,459 | +215.1% | 0.37% | +154.1% |
| Q2 2023 | $1,058,132 | -30.7% | 34,422 | -18.8% | 0.15% | -29.5% |
| Q1 2023 | $1,527,672 | – | 42,400 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |